LPCN: Lipocine Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 28.86
Enterprise Value ($M) 24.09
Book Value ($M) 20.37
Book Value / Share 3.83
Price / Book 1.42
NCAV ($M) 20.23
NCAV / Share 3.81
Price / NCAV 1.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.79
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 8.69
Current Ratio 8.69

Balance Sheet (mrq) ($M)
Current Assets 22.86
Assets 23.00
Liabilities 2.63
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue -2.85
Operating Income -17.93
Net Income -16.35
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.87
Cash from Investing 13.08
Cash from Financing 0.40

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 2,547 8,332 30.57
2024-04-17 3,305 34,899 9.47
2024-04-16 4,794 37,039 12.94
2024-04-15 5,415 95,973 5.64

(click for more detail)

Similar Companies
LIFE – aTyr Pharma, Inc. LIPO – Lipella Pharmaceuticals Inc.
LIXT – Lixte Biotechnology Holdings, Inc. LPTX – Leap Therapeutics, Inc.
LQDA – Liquidia Corporation


Financial data and stock pages provided by
Fintel.io


Finpedia: Lipocine Inc